A detailed history of Commonwealth Equity Services, LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 16,250 shares of PYXS stock, worth $27,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,250
Previous 16,250 -0.0%
Holding current value
$27,462
Previous $54,000 11.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$3.06 - $5.58 $42,840 - $78,120
-14,000 Reduced 46.28%
16,250 $54,000
Q1 2024

Apr 29, 2024

BUY
$2.03 - $6.59 $35,119 - $114,007
17,300 Added 133.59%
30,250 $129,000
Q3 2023

Oct 23, 2023

BUY
$1.6 - $2.78 $20,720 - $36,001
12,950 New
12,950 $26,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.